A gonadotropin-releasing hormone agonist (GnRH agonist) is a type of medication which affects gonadotropins and sex hormones. They are used for a variety of indications including in fertility medicine and to lower sex hormone levels in the treatment of hormone-sensitive cancers such as prostate cancer and breast cancer, certain gynecological disorders like heavy periods and endometriosis, high testosterone levels in women, early puberty in children, as a part of transgender hormone therapy, and to delay puberty in transgender youth among other uses. GnRH agonists are given by injections into fat, as implants placed into fat, and as nasal sprays.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Gonadotropin-releasing Hormone Agonist Drugs industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Leuprorelin
Goserelin
Taltirelin
Histrelin
Other
Market Segment by Product Application
Hospital
Pharmacy
Other
Finally, the report provides detailed profile and data information analysis of leading company.
AbbVie
Sanofi
TerSera Therapeutics
AstraZeneca
Ipsen
Ferring
LIVZON
Takeda
Endo
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Gonadotropin-releasing Hormone Agonist Drugs consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Gonadotropin-releasing Hormone Agonist Drugs market by identifying its various subsegments.
3.Focuses on the key global Gonadotropin-releasing Hormone Agonist Drugs manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Gonadotropin-releasing Hormone Agonist Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Gonadotropin-releasing Hormone Agonist Drugs submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Gonadotropin-releasing Hormone Agonist Drugs Professional Survey Report Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Gonadotropin-releasing Hormone Agonist Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Gonadotropin-releasing Hormone Agonist Drugs Segment by Type
2.1.1 Leuprorelin
2.1.2 Goserelin
2.1.3 Taltirelin
2.1.4 Histrelin
2.1.5 Other
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Pharmacy
2.2.3 Other
2.3 Global Gonadotropin-releasing Hormone Agonist Drugs Market Comparison by Regions (2017-2027)
2.3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Market Size (2017-2027)
2.3.2 North America Gonadotropin-releasing Hormone Agonist Drugs Status and Prospect (2017-2027)
2.3.3 Europe Gonadotropin-releasing Hormone Agonist Drugs Status and Prospect (2017-2027)
2.3.4 Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Status and Prospect (2017-2027)
2.3.5 South America Gonadotropin-releasing Hormone Agonist Drugs Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Gonadotropin-releasing Hormone Agonist Drugs Industry Impact
2.5.1 Gonadotropin-releasing Hormone Agonist Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Gonadotropin-releasing Hormone Agonist Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Gonadotropin-releasing Hormone Agonist Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Gonadotropin-releasing Hormone Agonist Drugs Manufacturer Market Share
3.5 Top 10 Gonadotropin-releasing Hormone Agonist Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Gonadotropin-releasing Hormone Agonist Drugs Market
3.7 Key Manufacturers Gonadotropin-releasing Hormone Agonist Drugs Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Gonadotropin-releasing Hormone Agonist Drugs Industry Key Manufacturers
4.1 AbbVie
4.1.1 Company Details
4.1.2 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification
4.1.3 AbbVie Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 AbbVie News
4.2 Sanofi
4.2.1 Company Details
4.2.2 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification
4.2.3 Sanofi Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Sanofi News
4.3 TerSera Therapeutics
4.3.1 Company Details
4.3.2 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification
4.3.3 TerSera Therapeutics Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 TerSera Therapeutics News
4.4 AstraZeneca
4.4.1 Company Details
4.4.2 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification
4.4.3 AstraZeneca Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 AstraZeneca News
4.5 Ipsen
4.5.1 Company Details
4.5.2 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification
4.5.3 Ipsen Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Ipsen News
4.6 Ferring
4.6.1 Company Details
4.6.2 Ferring Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification
4.6.3 Ferring Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Ferring News
4.7 LIVZON
4.7.1 Company Details
4.7.2 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification
4.7.3 LIVZON Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 LIVZON News
4.8 Takeda
4.8.1 Company Details
4.8.2 Takeda Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification
4.8.3 Takeda Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Takeda News
4.9 Endo
4.9.1 Company Details
4.9.2 Endo Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification
4.9.3 Endo Gonadotropin-releasing Hormone Agonist Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Endo News
5 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Categorized by Regions
5.1 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue, Sales and Market Share by Regions
5.1.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales and Market Share by Regions (2017-2022)
5.1.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue and Market Share by Regions (2017-2022)
5.2 North America Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
5.3 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
5.5 South America Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
6 North America Gonadotropin-releasing Hormone Agonist Drugs Market Size Categorized by Countries
6.1 North America Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Market Share by Countries
6.1.1 North America Gonadotropin-releasing Hormone Agonist Drugs Sales (Volume) by Countries (2017-2022)
6.1.2 North America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Countries (2017-2022)
6.1.3 United States Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
6.1.4 Canada Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
6.1.5 Mexico Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
6.2 North America Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) by Manufacturers
6.3 North America Gonadotropin-releasing Hormone Agonist Drugs Sales and Market Share by Type (2017-2022)
6.4 North America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2017-2022)
7 Europe Gonadotropin-releasing Hormone Agonist Drugs Market Size Categorized by Countries
7.1 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Market Share by Countries
7.1.1 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Countries (2017-2022)
7.1.3 Germany Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
7.1.4 UK Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
7.1.5 France Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
7.1.6 Russia Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
7.1.7 Italy Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
7.1.8 Spain Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
7.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) by Manufacturers
7.3 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales and Market Share by Type (2017-2022)
7.4 Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2017-2022)
8 Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Market Size Categorized by Countries
8.1 Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue by Countries (2017-2022)
8.1.3 China Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
8.1.4 South Korea Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
8.1.5 Japan Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
8.1.6 Australia Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
8.1.7 India Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue (Value) by Manufacturers
8.3 Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2017-2022)
9 South America Gonadotropin-releasing Hormone Agonist Drugs Market Size Categorized by Countries
9.1 South America Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Market Share by Countries
9.1.1 South America Gonadotropin-releasing Hormone Agonist Drugs Sales (Volume) by Countries (2017-2022)
9.1.2 South America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Countries (2017-2022)
9.1.3 Brazil Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
9.2 South America Gonadotropin-releasing Hormone Agonist Drugs Sales and Market Share by Type (2017-2022)
9.3 South America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2017-2022)
10 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Market Size Categorized by Countries
10.1 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Countries (2017-2022)
10.1.3 GCC Countries Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
10.1.4 Turkey Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
10.1.5 Egypt Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
10.1.6 South America Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales and Market Share by Type
10.3 Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2017-2022)
11 Global Gonadotropin-releasing Hormone Agonist Drugs Market Segment by Type
11.1 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales and Market Share by Type (2017-2022)
11.1.2 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue and Market Share by Type (2017-2022)
11.2 Leuprorelin Sales Growth Rate and Price
11.2.1 Global Leuprorelin Sales Growth Rate (2017-2022)
11.2.2 Global Leuprorelin Price (2017-2022)
11.3 Goserelin Sales Growth Rate and Price
11.3.1 Global Goserelin Sales Growth Rate (2017-2022)
11.3.2 Global Goserelin Price (2017-2022)
11.4 Taltirelin Sales Growth Rate and Price
11.4.1 Global Taltirelin Sales Growth Rate (2017-2022)
11.4.2 Global Taltirelin Price (2017-2022)
11.5.1 Global Histrelin Sales Growth Rate (2017-2022)
11.5.2 Global Histrelin Price (2017-2022)
11.6 Other Sales Growth Rate and Price
11.6.1 Global Other Sales Growth Rate (2017-2022)
11.6.2 Global Other Price (2017-2022)
12 Global Gonadotropin-releasing Hormone Agonist Drugs Market Segment by Application
12.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2017-2022)
12.2 Hospital Sales Growth Rate (2017-2022)
12.3 Pharmacy Sales Growth Rate (2017-2022)
12.4 Other Sales Growth Rate (2017-2022)
13 Global Gonadotropin-releasing Hormone Agonist Drugs Market Forecast
13.1 Global Gonadotropin-releasing Hormone Agonist Drugs Revenue, Sales and Growth Rate (2022-2027)
13.2 Gonadotropin-releasing Hormone Agonist Drugs Market Forecast by Regions (2022-2027)
13.2.1 North America Gonadotropin-releasing Hormone Agonist Drugs Market Forecast (2022-2027)
13.2.2 Europe Gonadotropin-releasing Hormone Agonist Drugs Market Forecast (2022-2027)
13.2.3 Asia-Pacific Gonadotropin-releasing Hormone Agonist Drugs Market Forecast (2022-2027)
13.2.4 South America Gonadotropin-releasing Hormone Agonist Drugs Market Forecast (2022-2027)
13.2.5 Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Market Forecast (2022-2027)
13.3 Gonadotropin-releasing Hormone Agonist Drugs Market Forecast by Type (2022-2027)
13.3.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Type (2022-2027)
13.3.2 Global Gonadotropin-releasing Hormone Agonist Drugs Market Share Forecast by Type (2022-2027)
13.4 Gonadotropin-releasing Hormone Agonist Drugs Market Forecast by Application (2022-2027)
13.4.1 Global Gonadotropin-releasing Hormone Agonist Drugs Sales Forecast by Application (2022-2027)
13.4.2 Global Gonadotropin-releasing Hormone Agonist Drugs Market Share Forecast by Application (2022-2027)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Gonadotropin-releasing Hormone Agonist Drugs Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Gonadotropin-releasing Hormone Agonist Drugs Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Gonadotropin-releasing Hormone Agonist Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Gonadotropin-releasing Hormone Agonist Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Gonadotropin-releasing Hormone Agonist Drugs Market Size by Type
Figure Global Market Share of Gonadotropin-releasing Hormone Agonist Drugs by Type in 2021
Figure Leuprorelin Picture
Figure Goserelin Picture
Figure Taltirelin Picture
Figure Histrelin Picture
Figure Other Picture
Table Global Gonadotropin-releasing Hormone Agonist Drugs Market Size (Volume) by Application
Figure Hospital Picture
Figure Pharmacy Picture
Figure Other Picture
Table Global Gonadotropin-releasing Hormone Agonist Drugs Comparison by Regions (M USD) 2017-2027
Figure Global Gonadotropin-releasing Hormone Agonist Drugs Market Size (Million US$) (2017-2027)
Figure North America Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Gonadotropin-releasing Hormone Agonist Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Manufacturer (2017-2022)
Figure Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Manufacturer in 2021
Table Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Manufacturer (2017-2022)
Figure Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Manufacturer in 2021
Table Global Gonadotropin-releasing Hormone Agonist Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Gonadotropin-releasing Hormone Agonist Drugs Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Gonadotropin-releasing Hormone Agonist Drugs Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Gonadotropin-releasing Hormone Agonist Drugs Market
Table Key Manufacturers Gonadotropin-releasing Hormone Agonist Drugs Product Type
Table Mergers & Acquisitions Planning
Table AbbVie Company Profile
Table Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification of AbbVie
Table Gonadotropin-releasing Hormone Agonist Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AbbVie 2017-2022
Table AbbVie Main Business
Table AbbVie Recent Development
Table Sanofi Company Profile
Table Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification of Sanofi
Table Gonadotropin-releasing Hormone Agonist Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2017-2022
Table Sanofi Main Business
Table Sanofi Recent Development
Table TerSera Therapeutics Company Profile
Table Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification of TerSera Therapeutics
Table Gonadotropin-releasing Hormone Agonist Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of TerSera Therapeutics 2017-2022
Table TerSera Therapeutics Main Business
Table TerSera Therapeutics Recent Development
Table AstraZeneca Company Profile
Table Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification of AstraZeneca
Table Gonadotropin-releasing Hormone Agonist Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AstraZeneca 2017-2022
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Ipsen Company Profile
Table Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification of Ipsen
Table Gonadotropin-releasing Hormone Agonist Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ipsen 2017-2022
Table Ipsen Main Business
Table Ipsen Recent Development
Table Ferring Company Profile
Table Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification of Ferring
Table Gonadotropin-releasing Hormone Agonist Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ferring 2017-2022
Table Ferring Main Business
Table Ferring Recent Development
Table LIVZON Company Profile
Table Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification of LIVZON
Table Gonadotropin-releasing Hormone Agonist Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of LIVZON 2017-2022
Table LIVZON Main Business
Table LIVZON Recent Development
Table Takeda Company Profile
Table Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification of Takeda
Table Gonadotropin-releasing Hormone Agonist Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Takeda 2017-2022
Table Takeda Main Business
Table Takeda Recent Development
Table Endo Company Profile
Table Gonadotropin-releasing Hormone Agonist Drugs Product Introduction, Application and Specification of Endo
Table Gonadotropin-releasing Hormone Agonist Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Endo 2017-2022
Table Endo Main Business
Table Endo Recent Development
Figure Global Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure Global Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2017-2022)
Table Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Regions (2017-2022)
Figure Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Regions in 2021
Table Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Regions (2017-2022)
Figure Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Regions in 2021
Figure North America Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure Europe Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure South America Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure North America Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2017-2022)
Table North America Gonadotropin-releasing Hormone Agonist Drugs Sales (Volume) by Countries (2017-2022)
Table North America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries (2017-2022)
Figure North America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries in 2021
Table North America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Countries (2017-2022)
Table North America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries (2017-2022)
Figure North America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries in 2021
Figure United States Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure Canada Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure Mexico Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Table North America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Manufacturer (2021)
Figure North America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Manufacturer in 2021
Table North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2017-2022)
Table North America Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Type (2017-2022)
Table North America Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2017-2022)
Table North America Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Application (2017-2022)
Figure Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2017-2022)
Table Europe Gonadotropin-releasing Hormone Agonist Drugs Sales (Volume) by Countries (2017-2022)
Table Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries (2017-2022)
Figure Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries in 2021
Table Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Countries (2017-2022)
Table Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries (2017-2022)
Figure Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries in 2021
Figure Germany Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure UK Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure France Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure Russia Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure Italy Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure Spain Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Table Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue by Manufacturer (2021)
Figure Europe Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Manufacturer in 2021
Table Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2017-2022)
Table Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Type (2017-2022)
Table Europe Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2017-2022)
Table Europe Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Application (2017-2022)
Figure Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2017-2022)
Table Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries in 2021
Table Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue by Countries (2017-2022)
Table Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries in 2021
Figure China Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure South Korea Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure Japan Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure Australia Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure India Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure Southeast Asia Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Table Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue by Manufacturer (2021)
Figure Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2017-2022)
Table Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Type (2017-2022)
Table Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2017-2022)
Table Asia-pacific Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Application (2017-2022)
Figure South America Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2017-2022)
Table South America Gonadotropin-releasing Hormone Agonist Drugs Sales (Volume) by Countries (2017-2022)
Table South America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries (2017-2022)
Figure South America Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries in 2019
Table South America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Countries (2017-2022)
Table South America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries (2017-2022)
Figure South America Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries in 2019
Figure Brazil Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Table South America Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2017-2022)
Table South America Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Type (2017-2022)
Table South America Gonadotropin-releasing Hormone Agonist Drugs Revenue by Type (2017-2022)
Table South America Gonadotropin-releasing Hormone Agonist Drugs Revenue Share by Type (2017-2022)
Table South America Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2017-2022)
Table South America Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Application (2017-2022)
Figure Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales (Volume) by Countries (2017-2022)
Table Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Countries in 2019
Table Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Countries (2017-2022)
Table Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries (2017-2022)
Figure Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Countries in 2019
Figure GCC Countries Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure Turkey Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure Egypt Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Figure South Africa Gonadotropin-releasing Hormone Agonist Drugs Sales and Growth Rate (2017-2022)
Table Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2017-2022)
Table Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Type (2017-2022)
Table Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue by Type (2017-2022)
Table Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Revenue Share by Type (2017-2022)
Table Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2017-2022)
Table Middle East and Africa Gonadotropin-releasing Hormone Agonist Drugs Sales Share by Application (2017-2022)
Table Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Type (2017-2022)
Table Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type (2017-2022)
Figure Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Type in 2021
Table Global Gonadotropin-releasing Hormone Agonist Drugs Revenue by Type (2017-2022)
Table Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Type (2017-2022)
Figure Global Gonadotropin-releasing Hormone Agonist Drugs Revenue Market Share by Type in 2019
Figure Global Leuprorelin Sales Growth Rate (2017-2022)
Figure Global Leuprorelin Price (2017-2022)
Figure Global Goserelin Sales Growth Rate (2017-2022)
Figure Global Goserelin Price (2017-2022)
Figure Global Taltirelin Sales Growth Rate (2017-2022)
Figure Global Taltirelin Price (2017-2022)
Figure Global Histrelin Sales Growth Rate (2017-2022)
Figure Global Histrelin Price (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Other Price (2017-2022)
Table Global Gonadotropin-releasing Hormone Agonist Drugs Sales by Application (2017-2022)
Table Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application (2017-2022)
Figure Global Gonadotropin-releasing Hormone Agonist Drugs Sales Market Share by Application in 2021
Figure Global Hospital Sales Growth Rate (2017-2022)
Figure Global Pharmacy Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022
AbbVie
Sanofi
TerSera Therapeutics
AstraZeneca
Ipsen
Ferring
LIVZON
Takeda
Endo